International Journal of Obstetric Anesthesia
Volume 16, Issue 4 , Pages 357-359 , October 2007

Recombinant factor VIIa should be used in massive obstetric haemorrhage

    Opposer:
  • M. Van de Velde, MD, PhD

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Marc Van de Velde, MD, PhD Director Obsteric Anaesthesia Department of Anaesthesiology, University Hospitals Gasthuisberg, Herestraat 49, B- 3000 Leuven, Belgium. Phone: 0032-16 34 42 70 Fax: 0032-16 34 42 45.

References 

  1. Confidential Enquiry into Maternal and Child Health. Why mothers die 2000-2002. London: RCOG Press; 86–95.
  2. Franchini M, Zaffanello M, Veneri D. Recombinant factor VIIa, an update on its clinical use. Thromb Haemost. 2005;93:1027–1035
  3. Rott H, Trobisch H, Kretzschmar E. Use of recombinant factor VIIa, Novo seven, in the management of acute haemorrhage. Curr Opin Anaesthesiol. 2004;17:159–163
  4. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777–785
  5. Bosch J, Thabut D, Bendtsen F, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterelogy. 2004;127:1123–1130
  6. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth. 2007;16:40–49
  7. Laffan M, O’Connell NM, Perry DJ, Hodgson AJ, O’Shaughnessy D, OP Smith. Analysis and results of the recombinant factor VIIa extended-use registry. Blood Coagul Fibrinolysis 2003;14:S35-8.
  8. Akyildiz M, Turan I, Ozutemiz O, Batur Y, Ilter T. A cerebrovascular event after single-dose administration of recombinent factor VIIa in a patient with esophageal variceal bleeding. Dig Dis Sci. 2006;51:1647–1649
  9. Basso IN, Keeling D. Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease. Blood Coagul Fibrinolysis. 2004;15:503–504
  10. de Jonge E, Friederich PW, Vlasuk GP, et al. Activation of coagulation by administration of recombinant factor VIIa elicits interleuking 6 (IL-6) and IL-8 release in healthy human subjects. Clin Diag Lab Immunol. 2003;10:495–497
  11. McCall P, Story DA, Karapillai D. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery. Can J Anaesth. 2006;53:926–933
  12. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Brit J Anaesth. 2005;94:592–595
  13. Esler MD, Douglas MJ. Planning for hemorrhage: Steps an anesthesiologist can take to limit and treat hemorrhage in the obstetric patient. Anesthesiology Clin N Am. 2003;21:127–144

PII: S0959-289X(07)00118-5

doi: 10.1016/j.ijoa.2007.06.002

International Journal of Obstetric Anesthesia
Volume 16, Issue 4 , Pages 357-359 , October 2007

Article Tools

* Image Usage & Resolution